Showing results (511-520 of 678) with videos related to
Sort By:
Pageof 68
Journal of Investigational Allergology & Clinical Immunology|November 23, 2013
Primary immunodeficiency in south China: clinical features and a genetic subanalysis of 138 childrenH Zeng, Y Tao, X Chen, et al.Neuroendocrinology|April 1, 2015
Impact of Previous Somatostatin Analogue Use on the Activity of Everolimus in Patients with Advanced Neuroendocrine Tumors: Analysis from the Phase III RADIANT-2 TrialLowell B Anthony, Marianne E Pavel, John D Hainsworth, et al.International Journal of Molecular Sciences|February 15, 2022
Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric TumorsShivanand Pudakalakatti, Mark Titus, José S Enriquez, et al.Cancer Research|January 21, 2010
Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activityZhiliang Jia, Yong Gao, Liwei Wang, et al.Cancer|April 15, 2021
Relationship between metabolic toxicity and efficacy of everolimus in patients with neuroendocrine tumors: A pooled analysis from the randomized, phase 3 RADIANT-3 and RADIANT-4 trialsNicola Fazio, Carlo Carnaghi, Roberto Buzzoni, et al.Chemical Communications (Cambridge, England)|July 14, 2016
Revealing instability and irreversibility in nonaqueous sodium-O2 battery chemistrySayed Youssef Sayed, Koffi P C Yao, David G Kwabi, et al.Surgery|December 20, 2005
Carcinoid tumors of the duodenumJohn T Mullen, Huamin Wang, James C Yao, et al.Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|November 29, 2022
[Real-world evidence and randomized controlled trials: the initiation, implementation, progress interpretation and revelation of RCT DUPLICATE (part 1)]S Y Shi, Z X Liu, H Y Zhao, et al.Chemical Communications (Cambridge, England)|December 3, 2016
Correction: Revealing instability and irreversibility in nonaqueous sodium-O2 battery chemistrySayed Youssef Sayed, Koffi P C Yao, David G Kwabi, et al.Pageof 68